ArticleParasitology2025
Cross-sectional assessment of feasibility and acceptability in screening for female genital schistosomiasis (FGS) in two clinical settings in East Province, Cameroon.
Article in Parasitology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Using precision mapping of schistosomiasis to guide female genital schistosomiasis (FGS) screening in Cameroon, sub-Saharan Africa.Parasitology · 2025Article
- Article
- Artificial Intelligence Image-Diagnosis for Female Genital Schistosomiasis.Mayo Clinic proceedings. Digital health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Africa, female genital schistosomiasis (FGS) damages women's health. In Cameroon, diagnosis is rare and healthcare workers lack knowledge. Clinicians can be trained to identify FGS lesions, but the accuracy is uncertain. We assessed the acceptability and feasibility of FGS screening in Cameroon's East Province by comparing static HIV clinics and mobile pop-up clinics through consultations and acceptance rates, guided by precise disease mapping. A clinician was remotely trained to diagnose FGS lesions, with success measured by expert comparison using cervix images. The proportion of FGS was compared between settings. A total of 1242 women were approached, 624 in the HIV clinics and 618 in the mobile clinics, respectively. Women at HIV clinics were significantly older [37.0 years (interquartile range, IQR: 31-43)] than those at mobile clinics [28.5 years (IQR: 23-36)]. Refusal of the screening procedures was significantly higher in the HIV clinics (50%) than in the mobile clinics (31%). FGS lesions were present in over half of women examined, 51% in the HIV clinic and 56% in the community. The diagnostic concordance between clinicians was more than 90%. It is both feasible and acceptable to identify and treat FGS lesions in areas without specialized care. Mobile pop-up clinics' acceptability is better, with younger women participating which helps to better rectify age-inequities in FGS surveillance, and remote telemedicine training is effective. Prevalence of FGS suspect lesions was very high in both settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.